The Will Soliman Podcast

At just 22 years old, Rob Long was living the dream, preparing himself to be one of the nation’s top football prospects out of Syracuse University, when everything changed in an instant.

After being diagnosed with a rare, incurable brain cancer and undergoing surgery that removed 25% of his brain, Rob was forced into a fight far bigger than football. What followed is a story of survival, resilience, identity, and purpose.

Today, his mission has shifted toward advancing rare disease research through UpLifting Athletes and helping others facing battles most people never see coming.

What happens when artificial intelligence starts designing medicines faster than the pharmaceutical industry can comprehend?

In this explosive conversation, Dr. Will Soliman sits down with Alex Zhavoronkov, CEO, one of the most provocative voices in AI drug discovery and the founder of Insilico Medicine, to discuss the future of medicine, longevity, biotech, and the AI arms race transforming pharma.

Fresh off Insilico’s multibillion-dollar deal with Eli Lilly, Alex explains why traditional pharmaceutical models are being disrupted, how AI-designed drugs are moving from theory to reality, and why most companies are still operating with what he calls “dinosaur AI.”

Hear why Alex says China is beating everyone in drug discovery and new patents, and its impact.

Are we losing the battle against preventable diseases? Watch Dr. Kelly Moore, CEO, and Dr. LJ Tan, Chief Policy Officer from Immunize.org, weigh in on “what is fact and myth”, along with Vaccine Committee Influencers, and what’s at risk for parents and children with Dr. Will Soliman.

• The Vaccine - Autism Myth to address the persistent misinformation regarding vaccines and autism. Hear from the experts.
• Understanding mRNA Technology as they break down how mRNA vaccines actually work and the recipe for your immune system.
• The Return of Measles, with outbreaks rising, is the U.S. at risk of losing its measles elimination status, and what parents need to know.
• Policy vs. Science: Exploring the role of the ACIP and Why Some States Are Now Opting to follow different clinical schedules.

Tune in to learn how parents can protect their children and themselves.

For the first time, former pharmaceutical sales rep Allison Marie Zayas tells her story as a whistleblower. What she witnessed in the pharma industry was shocking: the patients caught in the middle and the fallout that followed. Hear how a top-performing sales rep risked it all to protect patients from the potential risk of death.